Nasdaq
$4.27▲ 0.12%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $277.0MShares out 64.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
9- 10.2After-hours26.10.03 08:004Ownership#●●●#●●●
TREACE MEDICAL CONCEPTS, INC.
Insider Scot Michael Elder of Treace Medical Concepts, Inc. filed a Form 4 report regarding a change in beneficial ownership of securities as of September 30, 2026. This filing serves as an official notification to the SEC regarding the insider's equity transaction.…more
$4.27+0.12%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.24After-hours26.08.25 06:004Ownership
TREACE MEDICAL CONCEPTS, INC.
John T. Treace of Treace Medical Concepts, Inc. reported a change in beneficial ownership of company securities via SEC Form 4, effective August 20, 2026. This filing serves as a standard disclosure regarding the insider's updated equity holdings.…more
$4.27+0.12%vs prev closeView filingShare - 8.12After-hours26.08.13 07:004Ownership
TREACE MEDICAL CONCEPTS, INC.
Sean F. Scanlan, an executive at Treace Medical Concepts, Inc., reported a change in beneficial ownership of securities via SEC Form 4 on August 9, 2026. This filing formalizes the insider's change in stock holdings, and investors should review the details of the transaction.…more
$4.27+0.12%vs prev closeView filingShare
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 1d agoPre-market26.10.23 20:05#●●●#●●●
Treace Medical to Report Q3 2026 Financial Results on Nov 6
Treace Medical Concepts announced that it will release its financial results for the third quarter of 2026 before the market opens on November 6, 2026. Management will host a conference call following the release to discuss the company's financial performance.…more
$4.27+0.12%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.17After-hours26.09.18 06:17
●●●●●●●● ●●●●● ●●●●●●
Treace Medical announced the results of three clinical studies, including 5-year ALIGN3D data, demonstrating the long-term efficacy of its surgical treatments. While the clinical results are positive, their impact on the company's financial performance remains to be seen.…more
$4.27+0.12%vs prev closeShareBenzinga - 9.17After-hours26.09.18 06:16
●●●●●●●● ●●●●● ●●●●●●
Treace Medical presented 5-year clinical study data demonstrating the sustained effectiveness and safety of its Lapiplasty® bunion correction procedure. While the results validate the company's technology, they represent clinical evidence rather than immediate financial or operational growth.…more
$4.27+0.12%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report